Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid
Title: | Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid |
---|---|
Authors: | Kaspers, Gertjan, Mathot, Ron *, Ramnarain, Satianand *, Niewerth, Denise *, Locatelli, Franco, De Bont, Eveline S.J.M, Fagioli, Franca *, Rohrlich, Pierre *, von Stackelberg, Arend, Zwaan, Michel |
Source: | In Blood 15 November 2013 122(21):1439-1439 |
Database: | ScienceDirect |
ISSN: | 00064971 |
---|---|
DOI: | 10.1182/blood.V122.21.1439.1439 |
Published in: | Blood |
Language: | English |